IP Library Granted Patent US 10,952,461
Granted Patent B2
US 10,952,461 · App. 15/884,888 · Granted Mar 23, 2021

Translucent smokeless tobacco product

Inventor: Darrell Holton, Jr. (Clemmons, NC)
Assignee: R.J. Reynolds Tobacco Company
A24B15/24A24B15/10A24B15/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,952,461
App. No.
15/884,888
Granted
Mar 23, 2021
Kind
B2
Abstract

The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.

Claims (27)

1. A smokeless tobacco product comprising:

isomalt in an amount of at least about 90% by weight based on the total weight of the product;

maltitol in an amount of about 0.1% to about 2% by weight;

from about 1% to about 4% by weight percent of a salt; and

a tobacco extract, the smokeless tobacco product being in the form of a translucent lozenge,

wherein the tobacco extract consists of compounds having a molecular weight of less than about 50,000 Da.

2. The smokeless tobacco product of claim 1 , wherein the tobacco extract is an ultrafiltered tobacco extract characterized as translucent or transparent.

3. The smokeless tobacco product of claim 1 , wherein the tobacco extract is a heat-treated tobacco extract that has been treated prior to inclusion in the smokeless tobacco product by heating the tobacco extract in an aqueous solution comprising L-lysine, L-cysteine, asparaginase, or hydrogen peroxide.

4. The smokeless tobacco product of claim 3 , wherein the aqueous solution further comprises NaOH.

5. The smokeless tobacco product of claim 1 , wherein the tobacco extract is a heat-treated tobacco extract that has been treated prior to inclusion in the smokeless tobacco product by heating the tobacco extract in an aqueous solution comprising L-lysine and NaOH.

6. The smokeless tobacco product of claim 1 , wherein the tobacco extract consists of compounds having a molecular weight of less than about 5,000 Da.

7. The smokeless tobacco product of claim 1 , further comprising one or more flavorants.

8. The smokeless tobacco product of claim 7 , wherein the amount of flavorant is from about 0.1 to about 1.5 percent by weight of the smokeless tobacco product.

9. The smokeless tobacco product of claim 7 , wherein the flavorant is vanillin, coffee, cream, fruit, or mint flavor.

10. The smokeless tobacco product of claim 1 , further comprising at least one additional artificial sweetener.

11. The smokeless tobacco product of claim 10 , wherein the at least one additional artificial sweetener comprises sucralose.

12. The smokeless tobacco product of claim 1 , wherein the salt is NaCl.

13. The smokeless tobacco product of claim 1 , further comprising an outer coating.

14. The smokeless tobacco product of claim 1 , wherein the tobacco extract comprises nicotine.

15. A method of preparing a translucent smokeless tobacco product comprising: isomalt in an amount of at least about 90% by weight based on the total weight of the product; maltitol in an amount of about 0.1% to about 2% by weight; from about 1% to about 4% by weight percent of a salt; and a tobacco extract, the smokeless tobacco product being in the form of translucent lozenge, wherein the tobacco extract consists of compounds having a molecular weight of less than about 50,000 Da, comprising:

(i) mixing isomalt and maltitol in a melted state to form a first mixture;

(ii) heating the first mixture to or past the hard crack stage;

(iii) cooling the first mixture to a temperature of no more than about 132° C.;

(iv) forming a second mixture comprising a translucent or transparent tobacco extract comprising nicotine and one or more additional ingredients selected from flavorants, salts, and artificial sweeteners;

wherein the translucent or transparent tobacco extract has been treated by size exclusion chromatography, microfiltration, ultrafiltration, nanofiltration, reverse osmosis, or a combination thereof and wherein the treatment removes components having a molecular weight above about 50,000 Da;

(v) mixing the second mixture with the first mixture after the cooling step to form a combined mixture;

(vi) pouring the combined mixture into a mold to form a lozenge.

Continuity (3)
Continuation 14789020 · Jul 1, 2015
Division 13240525 · Sep 22, 2011
Related Publication 20180228204A1 · Aug 16, 2018
Cited By (2)
US 12,295,412 US 12,484,617